1. Home
  2. EXEL vs APG Comparison

EXEL vs APG Comparison

Compare EXEL & APG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • APG
  • Stock Information
  • Founded
  • EXEL 1994
  • APG 1926
  • Country
  • EXEL United States
  • APG United States
  • Employees
  • EXEL N/A
  • APG N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • APG Engineering & Construction
  • Sector
  • EXEL Health Care
  • APG Consumer Discretionary
  • Exchange
  • EXEL Nasdaq
  • APG Nasdaq
  • Market Cap
  • EXEL 9.7B
  • APG 10.1B
  • IPO Year
  • EXEL 2000
  • APG N/A
  • Fundamental
  • Price
  • EXEL $34.45
  • APG $35.37
  • Analyst Decision
  • EXEL Buy
  • APG Buy
  • Analyst Count
  • EXEL 18
  • APG 7
  • Target Price
  • EXEL $31.72
  • APG $44.00
  • AVG Volume (30 Days)
  • EXEL 2.6M
  • APG 1.8M
  • Earning Date
  • EXEL 10-29-2024
  • APG 10-31-2024
  • Dividend Yield
  • EXEL N/A
  • APG N/A
  • EPS Growth
  • EXEL 441.02
  • APG N/A
  • EPS
  • EXEL 1.55
  • APG N/A
  • Revenue
  • EXEL $2,081,598,000.00
  • APG $6,916,000,000.00
  • Revenue This Year
  • EXEL $20.53
  • APG $2.12
  • Revenue Next Year
  • EXEL $1.54
  • APG $6.19
  • P/E Ratio
  • EXEL $22.26
  • APG N/A
  • Revenue Growth
  • EXEL 17.31
  • APG 0.64
  • 52 Week Low
  • EXEL $19.20
  • APG $29.16
  • 52 Week High
  • EXEL $36.60
  • APG $39.98
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 67.10
  • APG 52.29
  • Support Level
  • EXEL $27.86
  • APG $36.00
  • Resistance Level
  • EXEL $36.49
  • APG $37.17
  • Average True Range (ATR)
  • EXEL 0.98
  • APG 0.94
  • MACD
  • EXEL -0.01
  • APG 0.06
  • Stochastic Oscillator
  • EXEL 74.10
  • APG 57.98

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About APG APi Group Corporation

APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.

Share on Social Networks: